Carregant...
Advances in the development of aptamer drug conjugates (ApDC) for targeted drug delivery
A key goal of modernmedicine is target-specific therapeutic intervention.However, most drugs lackselectivity, resulting in“off-target” side effects.To address the requirements of “targeted therapy,”aptamers, which are artificial oligonucleotides,have beenusedas novel targeting ligands to construct a...
Guardat en:
| Publicat a: | Wiley Interdiscip Rev Nanomed Nanobiotechnol |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507701/ https://ncbi.nlm.nih.gov/pubmed/27800663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.1438 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|